Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice

Dose reduction of biologics for psoriasis could contribute to lower drug exposure. This study evaluated a one-step, tightly controlled, biologic dose reduction strategy in a prospective daily practice cohort. In patients with psoriasis with low disease activity using adalimumab, etanercept or usteki...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Selma Atalay (Autor), Lara S. van der Schoot (Autor), Laura Vandermaesen (Autor), Lieke J. van Vugt (Autor), Mascha Eilander (Autor), Juul M.P.A. van den Reek (Autor), Elke M.G.J. de Jong (Autor)
Format: Knjiga
Izdano: Medical Journals Sweden, 2021-05-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno